Perioperative Biventricular Pacing Leads to Improvement of Hemodynamics in Patients with Reduced Left‐Ventricular Function—Interim Results

Abstract

Biventricular pacing leads to significant rise in cardiac output in approximately 59% of patients with severely reduced left ventricular function and widened QRS complexes. Further studies are necessary to define clearly the clinical characteristics of patients who show remodeling by CRT.

Permanent biventricular ICD-implantation in a heart failure second re-do-CABG patient: a case report

“…The acute hemodynamic improvement was also observed in the immediate postoperative course in patients undergoing open heart surgery with impaired left ventricular function [4-6]. Compared to conventional methods for treatment of perioperative heart failure like intra-aortic balloon implantation or administration of high doses of inotropic support, biventricular pacing can be easily initiated and is accompanied with almost no side effects.…”

“…In these patients resynchronization of the interventricular conduction system by biventricular stimulation leads to improvement of quality of life and NYHA (New York Heart Association) class [2,3]. In open heart operations the acute hemodynamic benefit of biventricular pacing can be used by implantation of temporary epicardial electrodes facilitating weaning from extracorporeal circulation in high risk patients with impaired left ventricular function and improving cardiac output postoperatively [4-6]. Intraoperative implantation of permanent epicardial pacing leads and devices can combine the immediate and the long-term advantages of biventricular stimulation.…”

Nontransplant surgical treatment for advanced heart failure

“…Dzemali et al [42] investigated hemodynamic effects of perioperative temporary BVP in patients undergoing cardiac surgery. Approximately 60% of patients responded to BVP with an increase in cardiac output and a synchronized ventricular contraction.…”

Atrioventricular delay programming in cardiac resynchronization therapy devices: fixed or adaptive?

“…[10][11][12][13] Briefly, the hemodynamic monitor (Aesculon, Osypka Medical, Berlin, Germany) measures changes in thoracic electrical bioimpedance during left ventricular ejection period, allowing for determination of SV, CO, CI based on the Bernstein-Osypka-formula, taking into account that the EV is affected by weight, height and heart rate. The measurements are easy to perform, requiring 4 standard surface adhesive electrocardiogram sensors positioned on the left side of the neck (n = 2) and on the lateral thorax (n = 2).…”